12
Mar

Sudden sensorineural hearing loss: role of hyperbaric oxygen therapy

Sudden sensorineural hearing loss (SSNHL) is defined as an acute hearing reduction, typically unilateral, of 30 dB or more in at least three consecutive frequencies, occurring within 72 hours of symptom onset. It was first described in 1926 as Citelli’s acute cochlear block and is currently more commonly referred to as idiopathic sudden sensorineural hearing loss (ISSNHL). There are approximately

Read more

26
Feb

Diabetic hand infections and hyperbaric oxygen therapy

According to the World Health Organization (WHO), 346 million people have diabetes worldwide and the number of diabetics is predicted to double between 2005 and 2030. Foot ulcers are one of the most important complications of diabetes and cause high rates of amputation. Diabetic hand infections are observed less frequently than foot infections. Hand infections related to diabetes have mostly

Read more

21
Feb

New center in Abu Dhabi

BioBarica opened a new center in Abu Dhabi. Ibrahim Shehata, the sales coordinator of the region, was present at the installation of the hyperbaric chamber and offered training to the staff that operates the unit. Hyperbaric chamber treatment is a non-invasive method that consists of supplying air and oxygen under pressure in a pressurized cabin at 1.4 atmospheres (ATM). The normal ambient atmospheric pressure is

Read more

21
Feb

The hyperbaric chamber: adjuvant of neurorehabilitation therapy

Stroke is the leading cause of disability in the world. It is estimated that of the 15 million people who have suffered one, 5 million have been left with permanent sequelae, such as motor, sensory disorders, urinary incontinence, speech alteration, and understanding, etc. “When a stroke occurs, the time to apply a treatment to return the blood supply and the

Read more

14
Feb

Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis

Hyperbaric oxygen has been used in patients with rheumatic disease for many years without reports of untoward or unusual complications for a variety of non-rheumatic indications. Recent evidence that hyperbaric oxygen inhibits the actions of certain cytokines, acts as an immune modulator and may help cognitive dysfunction has resulted in a re-examination of its potential role in rheumatic diseases. This

Read more

6
Feb

Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies

One of the major issues contributing to the ineffective medical treatment of cancer is the occurrence of local hypoxia within the central tumor areas. The application of hyperbaric oxygen therapy (HBOT) may help overcome the problem of oxygen deficiency in the poorly oxygenated regions of the neoplastic tissue. To date, several reviews on the use of HBO in cancer treatment

Read more

31
Jan

Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments

Painful bladder syndrome/interstitial cystitis (PBS/IC) is a collective term covering a range of clinical complaints and pathological findings. Approximately 10-50% of PBS/IC patients demonstrate a classical mucosal ulcer (Hunner’s ulcer), and the majority are diagnosed on the basis of positive factors and exclusions derived from the diagnostic criteria of the National Institute of Diabetes and Digestive and Kidney Diseases for

Read more

25
Jan

A study revealed that hyperbaric medicine temporarily reverses Alzheimer’s symptoms

Hyperbaric Oxygen therapy in a pressurized chamber (HBOT) allowed temporary improvements in the symptoms of a 58-year-old woman with Alzheimer’s. The authors of the study estimated that HBOT combined with medication can be an effective long-term therapy For the first time, it was documented, by positron emission tomography (PET) scans, that hyperbaric oxygen therapy (HBOT), a medical treatment based on 100%

Read more

21
Jan

Hyperbaric oxygen treatment induces antioxidant gene expression

Hyperbaric oxygen therapy (HBOT) has recently been promoted as an approach to slow aging. HBOT is the medical use of oxygen at higher than 1 atmosphere (atm) of pressure. The therapeutic principle behind HBOT stems from increasing the partial pressure of oxygen in the tissues of the body. In addition, HBOT increases the oxygen-carrying capacity of blood plasma beyond those

Read more

18
Jan

BioBarica continues to grow in Europe

BioBarica continues to grow in Europe. We opened two new service centers for HBOT, one in Milan, Italy and the other one in Maxeville, France. HBOT is a non-invasive method that consists in supplying oxygen at high concentrations in a pressurized hyperbaric chamber at a minimum of 1.4 ATM atmospheres (higher than the normal ambient atmospheric pressure of 1 atmosphere). The person is

Read more